Opus Genetics, Inc.
Public company- Headquarters
- DURHAM, North Carolina
- Ticker
- IRD
- CIK
- 0001228627
WARN notices since 2024
0
None on record
Workers affected since 2024
0
Across 0 notices
Executive changes, last 12 months
1
0 appointments, 1 departure
Last event
Oct 21, 2026
Executive departureChief Scientific and Development Officer departs: Ashwath Jayagopal
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| Chief Scientific and Development OfficerAshwath Jayagopal | Oct 21, 2026 | Departed |
Related companies
Same industry and state, with recent events.
- BRISTOL MYERS SQUIBB CO
WARN notice: Princeton, NJ
- JOHNSON & JOHNSON
WARN notice: New Brunswick, NJ
- Merck & Co., Inc.
WARN notice: Rahway, NJ
- NOVO NORDISK A S
WARN notice: Plainsboro, NJ
- Executive departure
Chief Scientific and Development Officer departs: Ashwath Jayagopal
Ashwath Jayagopal, Chief Scientific and Development Officer of Opus Genetics, Inc., departs the role, effective October 19, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 21, 2026Role: Chief Scientific and Development Officer
Only one public record so far. We add events as soon as a new filing lands; watch Opus Genetics, Inc. to get them in your digest.
Last verified Nov 10, 2026